Concepedia

T Wandert

TW

Statistics

Publications

9

Citations

1K

H-Index

9

Active since

1997

Affiliations

Medizinische Hochschule Hannover(Current)

Fachklinik Hornheide

Klinikum Ernst von Bergmann

University of Münster

T Wandert is an author at Medizinische Hochschule Hannover specializing in kidney cancer, oncology, and renal cell carcinoma.

Publications per year

1997–2005

9

Publications

9

Metastatic renal carcinoma comprehensive prognostic system

Jens Atzpodien, Patrick Royston, T Wandert et al. · British Journal of Cancer · 2003 · 242 citations · Full text

Medicine, Oncology, Pharmacology +17

Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Jens Atzpodien, Hartmut Kirchner, Udo Jonas et al. · Journal of Clinical Oncology · 2004 · 225 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Jens Atzpodien, E. Schmitt, Ulrich Gertenbach et al. · British Journal of Cancer · 2005 · 184 citations · Full text

Medicine, Immunology, Oncology +14

IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

Jens Atzpodien, Hartmut Kirchner, H.J. Illiger et al. · British Journal of Cancer · 2001 · 133 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma

Frederick Wittke, Reinhard Hoffmann, Jan Buer et al. · British Journal of Cancer · 1999 · 90 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 9